Medicare Enrolled
Dr. Dwight Bellingham, MD
Family Medicine · Statesville, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bellingham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bellingham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bellingham
Dr. Dwight Bellingham is a family medicine specialist in Statesville, NC, with 8 years of NPI registration. Based on federal Medicare data, Dr. Bellingham performed 2,083 Medicare services across 1,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bellingham received a total of $2,304 from 28 pharmaceutical and/or device companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bellingham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ Top 12% volume in NC
$2,304 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,083
Medicare services
Top 12% in NC for family medicine
1,548
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~260 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
419 | $80 | $169 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
188 | $1 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
171 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
161 | $8 | $29 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
120 | $10 | $54 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
109 | $16 | $70 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
100 | $13 | $58 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
97 | $125 | $170 |
| Annual depression screening | 92 | $18 | $35 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
82 | $9 | $46 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
50 | $5 | $46 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
48 | $29 | $45 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
44 | $72 | $85 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
38 | $46 | $158 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
38 | $10 | $49 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
33 | $8 | $39 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
30 | $19 | $60 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
26 | $29 | $72 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
26 | $67 | $175 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
19 | $18 | $48 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
17 | $44 | $224 |
| 3D screening mammography (tomosynthesis) A screening imaging test of the breast using 3D technology to detect potential abnormalities. |
17 | $21 | $125 |
| Screening mammography An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease. |
17 | $82 | $267 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
16 | $6 | $66 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
14 | $37 | $119 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
14 | $3 | $15 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
14 | $242 | $350 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $213 | $361 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
13 | $29 | $45 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
12 | $39 | $84 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
12 | $128 | $275 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
11 | $8 | $36 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $79 | $245 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $50 | $115 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,304
Total received (2018-2024)
Avg $329/year across 7 years
Top 18% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
139
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,304 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$522
2023
$664
2022
$713
2021
$314
2020
$27
2019
$14
2018
$50
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$134
Novo Nordisk Inc
$130
Amgen Inc.
$120
GlaxoSmithKline, LLC.
$33
Dexcom, Inc.
$28
Abbott Laboratories
$24
Axsome Therapeutics, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$15
ABBVIE INC.
$15
Top 3 companies account for 73.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$503
AstraZeneca Pharmaceuticals LP
$362
Amgen Inc.
$243
GlaxoSmithKline, LLC.
$207
ABBVIE INC.
$107
Abbott Laboratories
$107
AbbVie Inc.
$92
SANOFI-AVENTIS U.S. LLC
$83
PFIZER INC.
$80
Bayer HealthCare Pharmaceuticals Inc.
$72
Dexcom, Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Clarus Therapeutics Inc.
$43
Biohaven Pharmaceuticals, Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$33
Lilly USA, LLC
$30
Allergan, Inc.
$27
Axsome Therapeutics, Inc.
$23
EISAI INC.
$18
UPSHER-SMITH LABORATORIES LLC
$17
Otsuka America Pharmaceutical, Inc.
$17
Neos Therapeutics, LP
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Teva Pharmaceuticals USA, Inc.
$14
Merck Sharp & Dohme Corporation
$14
MannKind Corporation
$13
Exact Sciences Corporation
$13
Top 3 companies account for 48.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · AREXVY · Aimovig · Auvelity · BREZTRI · COMIRNATY · Cologuard Collection Kit · Cotempla XR-ODT · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GARDASIL9 · JARDIANCE · JATENZO · Kerendia · MOUNJARO · NURTEC ODT · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SYNTHROID · Saxenda · TEFLARO · TOSYMRA · TOUJEO · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Family medicine physicians within 10 mi
143
Per 100K population
74.6
County median income
$78,678
Nearest hospital
IREDELL MEMORIAL HOSPITAL INC
9.3 mi
9.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bellingham is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NC), with low-engagement industry engagement in the top 18% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bellingham experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bellingham performed 419 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bellingham receive payments from pharmaceutical companies?
Yes. Dr. Bellingham received a total of $2,304 from 28 companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bellingham's costs compare to other family medicine physicians in Statesville?
Dr. Bellingham's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bellingham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Statesville
Browse family medicine physicians in Statesville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology